kdigo guideline (2024): evaluation and management of chronic kidney disease MCQ (SBA): CKD G3b A3
Instant feedback + full explanation. One question, done properly.
Mediumeven without diabetes. DPP‑4 inhibitors (B)CKD G3b A3kdigo guideline (2024): evaluation and management of chronic kidney disease
Educational content. Not a substitute for clinical judgement or local policy.